Okay, let's tackle this question about which antidepressant is used for nocturnal enuresis. First, I need to recall what drugs are associated with this condition. Nocturnal enuresis, or bedwetting, is often managed with desmopressin, but the question specifies antidepressants. I remember that imipramine is an antidepressant used for this. Wait, is imipramine a tricyclic? Yes, and it's also used for overactive bladder. How does it work? It blocks norepinephrine reuptake, which might increase bladder capacity by reducing detrusor overactivity.

Now, looking at other antidepressants. SSRI like fluoxetine or sertraline—do they help? I don't think so. They're more for mood disorders. SNRIs like venlafaxine? Same issue. Maybe they have side effects that affect the bladder, but not primary treatment. Then there's TCAs. Imipramine is a TCA, so maybe other TCAs like amitriptyline are used? Wait, I think imipramine is specifically the one with that indication. Let me confirm: yes, imipramine is approved for nocturnal enuresis in children. It works by anticholinergic effects and increasing bladder capacity. So the correct answer should be imipramine.

Other options: if the choices are, say, fluoxetine, sertraline, venlafaxine, and imipramine, then imipramine is correct. The others are SSRIs or SNRIs not indicated here. Also, the mechanism is important—imipramine's anticholinergic properties help reduce nighttime urine production and increase bladder capacity. So the explanation should highlight that. The clinical pearl is that imipramine is the TCA used for this, and the first-line is desmopressin. So the correct answer is imipramine.

**Core Concept**
Nocturnal enuresis (bedwetting) is sometimes managed with antidepressants due to their anticholinergic and antinorepinephrine effects. Imipramine, a tricyclic antidepressant (TCA), is the only antidepressant approved for this indication. It increases bladder capacity and reduces nighttime urine production by blocking norepinephrine reuptake and antagonizing muscarinic receptors.

**Why the Correct Answer is Right**
Imipramine, a TCA, acts on the sympathetic nervous system to reduce detrusor overactivity and increase bladder compliance. Its anticholinergic effects decrease voiding frequency, while its norepinephrine reuptake inhibition enhances sympathetic tone in the bladder neck, promoting continence. It is particularly effective in children with primary monosymptomatic nocturnal enuresis. Clinical guidelines recommend imipramine as a second-line agent after desmopressin.

**Why Each Wrong Option is Incorrect**
**Option A:** *Fluoxetine* (SSRI) has no role in nocturnal enuresis. It treats depression and anxiety but lacks anticholinergic or bladder-specific mechanisms.
**Option B:** *Venlafaxine* (SNRI) is used for depression and generalized anxiety disorder. It increases norepinephrine and serotonin but is not indicated for en

✓ Correct Answer: A. Imipramine